<DOC>
	<DOCNO>NCT00113438</DOCNO>
	<brief_summary>This study evaluate safety effectiveness Combretastatin A4 Phosphate ( CA4P ) combine chemotherapy drug , carboplatin paclitaxel . The full treatment observation time 5 month . During time patient receive 18 CA4P infusion 6 carboplatin follow paclitaxel treatment . Patients randomize one two CA4P dose-level group order recommend prefer dose-level future study . At least 2 dynamic contrast enhanced-magnetic resonance imaging ( DCE-MRI ) scan conducted monitor blood flow tumor treatment CA4P .</brief_summary>
	<brief_title>Safety Effectiveness Combretastatin A-4 Phosphate Combined With Chemotherapy Advanced Solid Tumors</brief_title>
	<detailed_description>This phase II study evaluate safety efficacy Combretastatin A4 Phosphate ( CA4P ) combine carboplatin paclitaxel . Treatment maximum 6 consecutive 21-day cycle . Patients randomize onto one two CA4P dose arm ( 45 63 mg/m2 ) . CA4P administer day 1 , 8 15 cycle . Carboplatin paclitaxel ( AUC 6 200 mg/m2 , respectively ) administer day 2 cycle . At least 2 DCE-MRI scan perform evaluate change tumor blood flow follow treatment CA4P .</detailed_description>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Combretastatin</mesh_term>
	<mesh_term>Fosbretabulin</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Advanced malignancy treatment carboplatin paclitaxel warrant . Minimum 28day interval surgical , chemotherapy immunotherapy treatment 14day interval radiotherapy treatment . Radiologically measurable disease meet MRI perfusion criterion . ECOG performance status less equal 1 . Life expectancy great 12 week . Normal ejection fraction . Uncontrolled brain metastasis . Significant cardiac abnormality . Prior radiotherapy tumor site . Symptomatic peripheral vascular cerebrovascular disease . Uncontrolled hypertension .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>cancer</keyword>
	<keyword>tumor</keyword>
	<keyword>imageable</keyword>
	<keyword>CA4P</keyword>
	<keyword>Combretastatin</keyword>
	<keyword>Combretastatin A4 Phosphate</keyword>
	<keyword>Combretastatin A-4 Phosphate</keyword>
	<keyword>Carboplatin</keyword>
	<keyword>Paclitaxel</keyword>
	<keyword>carbo</keyword>
	<keyword>taxol</keyword>
</DOC>